Organisers of The Vet Charity Challenge, which last year raised £50,000 for charity, have announced that the event will take place Saturday 27th September 2014 in Pewsey, near Marlborough, Wiltshire.
The event consists of teams of four walking/running, cycling and kayaking as well as some orienteering and mental and physical tasks.
Registration will open at the start of April. Organisers say that spaces are limited and in 2013 filled up very fast, so early booking is advisable.
The charities being supported in 2014 will be Hearing Dogs for Deaf People, SPANA and Cats Protection.
The Vet Charity Challenge is sponsored by BCF Technology, Kruuse and Vetoquinol and supported by the VMPA and Veterinary Practice magazine.
For more information visit www.vetcharitychallenge.co.uk.
A study published in Current Biology has demonstrated that there are remarkable similarities in the way that dog and human brains respond to sound, and that dog brains, like those of people, are also sensitive to acoustic emotional cues.
Lead by Attila Andics, researchers from MTA-ELTE Comparative Ethology Research Group in Hungary trained 11 dogs to lay motionless in an fMRI brain scanner. This made it possible to run the same neuroimaging experiment on both dog and human participants - something that had never been done before. They captured both dogs' and humans' brain activities while the subjects listened to nearly 200 dog and human sounds, ranging from whining or crying to playful barking or laughing.
The resultant scans showed that dog and human brains include voice areas in similar locations. Not surprisingly, the voice area of dogs responds more strongly to other dogs while that of humans responds more strongly to other humans.
The researchers also noted striking similarities in the ways the dog and human brains process emotionally loaded sounds. In both species, an area near the primary auditory cortex lit up more with happy sounds than unhappy ones. Andics says the researchers were most struck by the common response to emotion across species.
There were some differences, too: in dogs, 48% of all sound-sensitive brain regions respond more strongly to sounds other than voices. That's in contrast to humans, in which only 3% of sound-sensitive brain regions show greater response to nonvocal versus vocal sounds.
The researchers say that the findings suggest that voice areas evolved at least 100 million years ago, the age of the last common ancestor of humans and dogs. It also offers new insight into humans' unique connection with our best friends in the animal kingdom and helps to explain the behavioural and neural mechanisms that made this alliance so effective for tens of thousands of years.
Andics said: "This method offers a totally new way of investigating neural processing in dogs. At last we begin to understand how our best friend is looking at us and navigating in our social environment."
Photograph: Borbala Ferenczy. Dogs at the MR Research Centre (Budapest).
A new US colic study, published in Equine Veterinary Journal (EVJ), in partnership with the American Association of Equine Practitioners, has identified various risk factors, including delayed faecal output and increasing blood lactate, associated with post-anaesthetic colic.
The study Risk factors associated with gastrointestinal dysfunction in horses undergoing elective procedures under general anaesthesia was conducted by surgeons based at the College of Veterinary Medicine and Biomedical Sciences at Colorado State University, USA.
The authors say that the research should enable vets to implement preventative measures to help reduce incidences of colic in the future.
Gastrointestinal pain has been estimated to occur in 2.8-6% of horses following general anaesthesia for elective procedures, the most common cause being impaction of the large intestine or caecum.
The medical records of 416 horses undergoing general anaesthesia were collected over a two-year period and the potential risk factors were examined. 8.7% of horses were diagnosed with gastrointestinal dysfunction - higher than previous estimates probably because the study included horses requiring treatment for decreased faecal output whereas previous studies did not. Potential risk factors were assessed, including faecal output, which was decreased in 38.9% of cases, blood lactate, position during surgery, rectal temperature and breed of horse.
The results showed that Arabian horses, increasing blood lactate, right lateral recumbency, decreased rectal temperature post-procedure and delayed passage of faeces were significantly associated with an increased risk of gastrointestinal dysfunction.
Diana Hassel, who instigated the study, said: "These findings should help the clinician identify higher risk horses and be proactive about their management in the post-anaesthetic period.
"This may include pre-emptive nasogastric intubation and administration of mineral oil and/or water and electrolytes. Although core temperature control in horses is difficult to achieve in adult horses during surgery, further research into this field may prove beneficial."
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "This study brings obvious and immediate practical benefits for clinicians and the horses under their care. Rigorous monitoring of higher risk surgical cases should lead to a reduction in incidences of post-operative colic, making recovery procedures less difficult and outcomes more favourable."
Royal Canin has announced the launch of two new veterinary diets designed to tackle obesity in cats and dogs.
'Satiety Small Dog' is for adult dogs with an ideal weight up to 10kg. 'Satiety Wet' has been developed for those dogs who prefer wet food, or who are used to eating a combination of wet and dry food.
Satiety Small Dog is available in 1.5kg, 3.5kg and 8kg bags and contains a blend of fibres that Royal Canin says increases the volume of stomach contents and promotes satiety. The company says the new diet also contains specific nutrients which contribute to maintaining good oral health, and a high protein content to help maintain muscle mass during the weight loss programme.
Satiety Small Dog is designed to improve digestive tolerance in smaller breeds, as it has a different blend of fibre and higher levels of butyrate than Satiety Canine, which is formulated for the needs of medium and larger dogs. The diet contains less dietary oxalate which Royal Canin claims is of benefit to smaller dogs that are at a greater risk of developing calcium oxalate uroliths.
The second new diet, Satiety Wet for Dogs, is available in 410g and 195g cans. The diet has a high protein content (14.1g per 100kcal), and is enriched with nutrients, minerals and vitamins. Royal Canin also highlights what it says is a particularly innovative feature: a high fibre content in a canned diet.
Ian Williams, Veterinary Scientific Support Manager at Royal Canin, said: "Almost 60% of dogs and 40% of cats in the UK and Ireland are overweight or obese. With obesity comes an increased risk of animals developing conditions affecting the upper respiratory tract, cardiopulmonary system, joints and urinary tract. In cats obesity is also a major risk factor for Type II diabetes mellitus. In essence, obesity can lead to a decreased life expectancy and a reduced quality of life.
"Royal Canin has a proven track record of developing innovative diets to help these pets and the latest additions to our range really will complement the existing choice for vets and their clients."
Following reports that a puppy in Cornwall has died after biting into an e-cigarette refill, the BVA is warning pet owners to ensure they are kept out of reach of animals.
BVA President Robin Hargreaves said: "This is a tragic case and very worrying when you consider how many people are now using e-cigarettes. Nicotine poisoning acts very quickly and can be fatal, especially when large doses are involved. E-cigarettes and refills can easily contain sufficient quantities of nicotine to kill a small animal very quickly.
"If you use e-cigarettes, we recommend storing all equipment safely out of reach of your pet. If you suspect your pet has chewed or eaten an e-cigarette or any toxic substance then it is vital that you contact a vet for treatment as quickly as possible."
The BVA says it understands that the female puppy was a recently rehomed Staffordshire cross. It became unwell on Sunday after apparently consuming an e-cigarette refill and died on Monday morning after failing to respond to treatment.
Dechra Veterinary Products has launched Anesketin, an anaesthetic licensed for cats, dogs and horses.
Anesketin contains ketamine 100mg/ml solution for injection and is indicated for induction of anaesthesia. In cats, it can also be used as a sole agent for restraint and minor surgical procedures where muscle relaxation is not required.
Dechra Brand Manager Carol Morgan said: "Anesketin is a versatile product which can be used as a sole agent in cats or in combination with appropriate sedatives and analgesics in cats, dogs and horses for induction and maintenance of anaesthesia.
Anesketin is available in 10 ml vials. The withdrawal period for meat, offal and milk is one day and the product does not require any special storage conditions.
For further information, visit www.dechra.co.uk
Novartis Animal Health has launched 'The Wormer Decision Tree', an online tool to help veterinary surgeons in giving sheep farmers the most up-to-date advice about worming.
Lesley Stubbings, SCOPS representative and Independent Sheep Consultant said: “Choosing the right wormer group is hugely important and there remains much confusion especially when it comes to anthelmintic resistance.
“Worms, including resistant and multi-resistant species, are threatening the productivity of sheep farms. However with a well-thought-out worming strategy that uses both the new wormer groups, in association with existing wormers, it is possible to slow resistance.”
Results of the Farming Against Wormer Resistance (FAWR) campaign survey, conducted in 2013, revealed growing concern about wormer resistance among farmers - but confusion about the best course of action to take.
Fiona Anderson, Novartis Animal Health Veterinary Manager said: "This tool has been developed adhering to SCOPS principles and is designed to ensure a consistent responsible approach is used when prescribing anthelmintics.
"Available only to SQPs and vets, it will be a valuable tool to train new staff and use with farmers, to explain which of the five drench classes are appropriate for particular sheep groups at specific times of year."
The Novartis Wormer Decision Tree asks three key questions: the type of sheep being dosed, the purpose of the dose, and the farm's resistance status. It then produces a recommendation of the required active ingredient, along with more detailed information to support the recommendation. There is also a calculator which provides a dose rate and cost per dose based upon the recommendation.
To use the decision tree, you must first register on the Novartis Farm Animal Health website: www.farmanimalhealth.co.uk. Then head here: www.farmanimalhealth.co.uk/wormerdecisiontree
The RSPCA reports that it has saved nearly 400 animals from flooding, including 40 fish, in the last 3 days alone.
The koi carp were rescued from a pond in Wraysbury, Berkshire, which was being overcome by rising floodwater.
Other rescues have included:
The charity says its flood rescue team has helped 586 animals affected by floods since Jan, with 386 of those in the last three days alone. Their efforts were praised by Labour leader Ed Milliband yesterday, who was at the scene with an RSPCA water rescue team in Wraysbury.
RSPCA flood rescue co-ordinator Jason Finch said: "The water rescue teams on the ground are doing an amazing job with limited resources. We will continue to do everything we can to help animals, and humans, during this difficult time and are so grateful for all the support our workers have received from the public."
Photograph courtesy RSPCA
Surrey vet Matthew Morgan has been struck off by the RCVS Disciplinary Committee after being convicted and imprisoned for four counts of pet insurance fraud.
Mr Morgan was convicted, upon his own confession, of dishonestly making false representations to make gain for himself/another or to cause loss to other/ expose other to risk on 22 July 2013 at the Central Criminal Court and, on 23 August 2013, was sentenced to two years' imprisonment.
The Disciplinary Committee heard that Mr Morgan, who was not present at the hearing but represented by Mr Laurence Imrie, Solicitor Advocate, had, between 13 November 2009 and 21 December 2012, taken out 18 insurance policies for veterinary cover with four separate insurance providers - Direct Line, Pet Plan, Pet Protect and Sainsbury's - in relation to a number of pets. Of these pets, only one, namely his pet cat, actually existed - the rest were fictitious.
During this period, the respondent made 50 claims on the insurance policies, seeking payment to reimburse him for the cost of veterinary treatment for the fictitious animals and also making false claims for treatment for his own pet cat, including for invented injuries 'sustained' during a non-existent car accident. As a result of the claims, the insurance companies made 54 payments to Mr Morgan to which he was not entitled, totalling £198,295.
At the time he began committing the offences Mr Morgan was working as a veterinary surgeon at a practice in Kent and, in order to support his fraudulent claims, used the practice's official stationery and stamps to fabricate invoices, clinical records and insurance claims. He continued to make fraudulent claims after leaving the practice, having taken the practice's headed paper and stamp with him.
Mr Morgan's actions came to light in December 2012 after submitting a claim to Direct Line for an operation on the spine of his own cat. The insurance company became suspicious and contacted the Kent practice which confirmed he had not treated the cat. An investigation by the insurers and, subsequently, the police began.
On 31 December 2012 Mr Morgan voluntarily attended a police station where he admitted fraudulently claiming £5,534.52 from Pet Plan and £7,610.03 from Direct Line, citing financial pressure caused by divorce, but failed to admit to the rest of his fraudulent activities. He was arrested on 25 January 2013 and, upon searching his home, police found the stamp and headed paper along with documents relating to the insurance claims.
The Disciplinary Committee, in considering the conduct of Mr Morgan, took into account a number of serious aggravating factors. This included the very high degree of financial gain from the fraudulent activities, the fact that there were 50 separate premeditated acts of dishonesty over a three-year period, the betrayal of trust of his former employer and the insurance companies, the potential reputational risk for his former employer, the abuse of his position as a veterinary surgeon and the fact that completion of insurance claims is an act of veterinary certification.
The Committee also considered, in mitigation, a letter from Mr Morgan to the Committee, three testimonials and representation from his legal representative. These cited the fact that Mr Morgan, when he committed the fraudulent activities, was heavily in debt, had serious domestic difficulties and was suffering from depression, although no medical evidence was submitted to the Committee.
However, it was the Committee's decision that the sanction of removing Mr Morgan from the Register had to be taken, in order to protect animal welfare and maintain public confidence in the profession.
Chairing and speaking on behalf of the Disciplinary Committee its Vice-Chairman, Ms Judith Webb, said: "The Committee is of the view that the Respondent's conduct in this case was deplorable ... Such conduct can only undermine public confidence in the profession. The Respondent abused his position as a veterinary surgeon to perpetrate a deliberate long-term fraud on insurers for personal gain.
"The Committee is conscious that its role is not to punish but to protect animal welfare and maintain public confidence in the profession. Due to the serious nature of the matters before it...the Committee has no doubt that the only suitable sanction is to direct the Registrar to remove the Respondent's name from the Register."
The Committee's full findings and decision are available on the RCVS website (www.rcvs.org.uk/disciplinary).
A new study from the University of Surrey, published today in the journal PLOS One, has identified the specific effects of a malformation which affects affects toy breeds.
According to researchers, Chiari malformation has become prevalent as a result of selective breeding and affects many toy dog breeds which have been bred to look more doll-like, including Griffon Bruxellois, Cavalier King Charles Spaniels, Chihuahuas and their crosses.
Researchers took brain, skull and vertebrae measurements of 155 Griffon Bruxellois and compared dogs affected by the condition with normal Griffons. They discovered that Griffons with the disease had taller foreheads and that it had also caused the shape of the brain to change, with severely affected animals having their cerebellum pushed underneath the main part of the brain.
The researchers say that although it can be asymptomatic, in many dogs Chiari malformation can cause headaches, problems with walking or even paralysis.
The condition can also affect humans and the University is working with human geneticists at the University of Montreal, in the hope that better understanding of the condition will lead to improved treatment for both dogs and humans.
Lead author, Dr Clare Rusbridge from the new School of Veterinary Medicine at the University of Surrey, said: "Chiari malformation can be described as trying to fit a big foot into a small shoe. It can be very painful, causing headaches and pressure on the brain and can result in fluid filled cavities in the spinal cord. Our latest discoveries will be significant in driving this research forward and hopefully allow us to identify which genes may be associated with the condition.
"Our next steps will be to apply our technique to other breeds with Chiari malformation and investigate more sophisticated ways of screening, so that risk of disease can be detected more easily, at an earlier age and with a single MRI scan.
"We want to engage breeders and give them practical advice about the condition, but it is also important that the public recognises that breeding dogs in a certain way to influence how they look might not be in the animal's best interest. There are responsible breeders out there, who have invested in screening and who are breeding for health as well as producing attractive puppies, and it is vital that people only look to buy from them."
Grahame Gardner has launched 'Smitten', a new range of scrubwear for women with a 20% introductory discount.
The company says the new range incorporates the influence of streetwear, resulting in a relaxed scrubwear collection which young and style conscious staff will love.
The fabrics used in the new range have been designed for the working environment. The first fabric to be launched to the UK market is 'Miracle' a stretchable and comfortable fabric which Grahame Gardner says feels great to the touch, but wears well and complements the fashionable garment styles.
James Greenlees, Managing Director at Grahame Gardner said: "There is no question that Scrubwear has come a long way over the past decade and at Grahame Gardner we have played a major part in this evolution, firstly with the hugely popular Urbane Scrubs and now Smitten. Smitten represents the next incarnation of scrubwear, and allows more individuality than ever before within healthcare uniforms. We cannot wait to get this out into the workplace as we know it will certainly make a real impact with our customers."
More information can be found at www.grahamegardner.co.uk, under scrubs and patientwear within the GG Collection.
The Animal Welfare Foundation (AWF) has produced a leaflet which guides pet owners through the euthanasia decision making process.
The leaflet 'Saying goodbye - the ultimate kindness' explains why euthanasia may be the most caring option, the choices owners have, the different ways euthanasia may be performed and what happens next. It also addresses the emotions owners may go through when deciding to put their pet down.
AWF Chairman Tiffany Hemming said: "As vets we often see pet owners struggle with letting their pet go. Guilt may be the strongest emotion owners feel when deciding to put their pet down. We wanted to guide owners through this difficult time in a sensitive way and encourage them to ask questions and work with the vet to help them come to terms with the end of their pet's life.
"While the leaflet is aimed at pet owners we hope vets find it a useful communication tool during this distressing time for their clients."
To see all AWF leaflets including 'Pre- and post-operative care', 'Pet travel', 'Pets and poisons', and 'What makes my pet happy' visit http://www.bva-awf.org.uk/pet-care-advice.
Practices can order batches of the leaflets for clients in return for a donation to AWF by contacting bva-awf@bva.co.uk.
Nick Stace, CEO of the Royal College of Veterinary Surgeons (RCVS), has issued a swift and robust response to the call by Unite for a shake up for the profession's regulatory system.
"Unite's suggestion that veterinary regulation should be under the scrutiny of the Professional Standards Authority (PSA) is misguided, because the PSA is there to oversee regulation in the human healthcare sector and the RCVS already has Department for Environment, Food and Rural Affairs (Defra) and Privy Council oversight.
"Its further thoughts around the RCVS disciplinary process are out of date and missing the point. We would be very happy to help put them right and to hear any legitimate concerns they may have.
"Unite is calling for the College to no longer 'set the rules and hand down judgments', when in fact last year we successfully achieved a Legislative Reform Order, backed by the profession, to ensure that our Disciplinary and Preliminary Investigation Committees will become independent from Council.
"Unite also talks about the profession's disquiet about last year's Disciplinary Hearing into Mr Chikosi, something we are well aware of and are currently responding to by looking at the biggest area of concern, the provision of 24/7 emergency cover. Our fact-finding mission is seeking views from the profession and the public.
"More broadly, though, feedback from our First Rate Regulator initiative has shown that the profession does have confidence in our disciplinary procedures and that they are certainly not subject to 'long-standing discontent'.
"The First Rate Regulator initiative is also leading to significant improvements in the way that complaints are handled, including speed to resolution.
"Unite is seeking to recruit members of the veterinary team as members of its union and it may be more successful in that pursuit if it was to start to understand the profession better, perhaps beginning with getting its facts right.
"We would be delighted to meet with Unite to put them right where they are factually wrong, and hear what they have to say."
Unite and the British Veterinary Union (BVU) have written to the government asking for the Professional Standards Authority (PSA), which regulates such governing bodies as the General Medical Council, General Dental Council, and Nursing and Midwifery Council (NMC), to have 'scrutiny' of the RCVS.
In a letter to junior minister at the Department for Environment, Food and Rural Affairs, George Eustice, the BVU chair Dr Shams Mir cited the case of Munhuwepasi Chikosi struck off the register of veterinary surgeons by the RCVS in June 2013.
Dr Mir said that this case was "widely seen by the veterinary profession as blatant miscarriage of justice and many expressions of 'outrage' were published in the veterinary press and online.
"One popular online veterinary forum recorded over a thousand posts criticising and challenging various aspects of the decision."
The current statutory duties of the RCVS, established by Royal Charter in 1844, are determined by the Veterinary Surgeons Act (VSA) of 1966, which Unite says is now 'outdated.
Dr Mir said: "BVU petitions the government to extend the remit of the PSA to incorporate the RCVS to ensure appropriate overview and scrutiny.
"The RCVS proposed new Royal Charter could be exploited by the RCVS to give itself proxy powers to introduce incontestable new regulatory measures."
Unite has asked for an urgent meeting with Mr. Eustice.
Unite professional officer Jane Beach said: "Our initiative is designed to safeguard the interests of both the public, and practicing vets and veterinary nurses in the UK.
"Basically, the way that the RCVS is presently constituted means that it is both judge and jury in disciplinary matters. It sets the rules and hands down the judgements - and we believe that an extra layer of scrutiny needs to be introduced which we would like to be the PSA."
Vetsonic has taken over the marketing of Cavalesse, the oral nutritional supplement for horses that are prone to skin allergies, such as sweet itch.
Cavalesse contains a formulation of water-soluble vitamins and minerals, administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat. Vetsonic claims the supplement helps horses maintain a healthy skin and promotes normal immune function.
Ray Rochester, Managing Director of Vetsonic said: "It's an exciting phase in the development of Vetsonic which will see us rapidly expanding in the increasingly competitive small animal and equine market. Cavalesse is a welcome addition to our portfolio."
For further information, contact Vetsonic customer services on 01653 695333.
Novartis Animal Health has announced the launch of a campaign to improve awareness of and improve education about atopic dermatitis (AD), to coincide with the 10th anniversary of Atopica.
As part of the campaign, the company is inviting veterinary surgeons to take part in an online survey for the chance to win an iPad mini: www.surveymonkey.com/s/atopica
In addition, Novartis says it will be offering all sorts of new educational materials for both vets and owners, including research into current trends and attitudes towards AD, insights from experts in the field, and case studies.
Ricardo Garvao, Category Manager for Atopica said: "This year marks an important milestone for the Atopica brand that wouldn't have been possible without the backing of so many vets. Continued investment by Novartis Animal Health into research and education seems a fitting way to extend thanks for this support and so forms one of the key elements of the 'Decade of Comfort' campaign. I am constantly amazed at just how dedicated and hard-working vets are and am immensely proud that Novartis Animal Health shares their goal to help pets remain happy and healthy."
Bayer Animal Health has announced the results of a survey1 which shows that despite 80% of dog owners being aware of lungworm (Angiostrongylus vasorum), 85% of dogs remain unprotected against the parasite.
The survey, which was carried out amongst 1,000 dog owners, also found that more than 5% had encountered lungworm in their own dogs. However, only 15% of owners treat their pet against parasites on a monthly basis, with the remainder admitting to missed routine lungworm worming treatments or not treating at all.
Bayer highlights evidence from the Royal Veterinary College2, which confirms the lungworm parasite has spread across the UK from its traditional habitat in the south of England and Wales, and is now widespread in Central England, also reaching northern regions and Scotland, with one in five vet practices nationwide reporting at least one case of the parasite. In another survey of 150 veterinary practices across the UK a total of 952 suspected cases were reported (157 laboratory confirmed), with 81 deaths thought to have been caused by the parasite3.
To encourage more pet owners to take action, Bayer will launch a consumer campaign called 'Act on Lungworm' in March. The campaign will include the world's first 24-hour radio station for dogs and their owners, 'Hound Waves', broadcasting live from Crufts on Friday 7th March. The event will also see the launch of a new television and advertising campaign from Bayer.
For veterinary professionals, the campaign launch will also include online videos detailing the 'ACT on Lungworm' veterinary support and showing the new television advertisement exclusively to vets before the national launch.
Caroline Braidwood, Group Product Manager at Bayer Animal Health said: "After launching the 2013 lungworm awareness campaign and providing owners with a social media platform, we quickly began to recognise the enthusiasm that exists to encourage action.
"We received feedback from owners who had tragically lost their pets to lungworm, and whilst we were pleased that we were helping to raise awareness, we became conscious that we needed to do more to prevent dogs from dying unnecessarily. Our 2014 campaign focus has come as a direct result of talking to these owners and providing individuals like Sandra Stevens with a platform to discuss their experiences in the hope that more owners will take action before it is too late."
'ACT on Lungworm' is part of Bayer Animal Health's wider 'It's a Jungle Out There' parasite protection initiative. Further information is available at www.facebook.com/jungleforpets
References
Ceva Animal Health has launched Vectra 3D, a broad spectrum topical ectoparasiticide for dogs which is effective against fleas, ticks and flies.
Vectra 3D contains a formulation of a brand new active called dinotefuran, pyriproxyfen and permethrin.
According to the company, Vectra 3D provides a rapid flea kill within two hours for dogs on current treatment and complete protection against the major vectors: fleas, ticks, sand flies, mosquitoes and stable flies1. Additionally, because dinotefuran kills on contact, it is claimed to reduce the incidence of flea feeding1.
Vectra 3D is applied in a line from the base of the tail to the neck using a patented applicator with an elongated tip, designed to make it easy to apply the product through the hair directly onto the skin. The applicator is also designed to provide accurate dosing without making any mess, as nothing comes out until the tube is squeezed.
Ceva highlights that the number of people travelling with their pets has increased by 61% since 20122, and that Vectra 3D is the only topical ectoparasiticide that offers repellent action against sand flies for one month, together with protection against mosquitoes and stable flies.
Julia Wood, product manager at Ceva Animal Health said: "Vectra 3D is an innovative formulation which uses a unique, easy-to-administer applicator to provide complete protection against fleas, ticks and flies. And with spring nearly upon us, it's time to start talking to clients about flea treatments, such as Vectra 3D."
To support the launch of Vectra 3D, Ceva is hosting a series of CPD meetings at venues across the UK. Accounting for two hours CPD, the afternoon meetings will cover vector-borne diseases, the importance of ticks in the UK and product information on Vectra 3D. They will be presented by Ian Wright BVMS BSc MSc MRCVS and Richard Wall BSc MBA PhD FRES and take place at:
For further information, contact your Ceva Animal Health territory manager or email Ceva Animal Health on customerservicesuk@ceva.com.
Zoetis has announced the launch of Apoquel (oclacitinib maleate), a new treatment for pruritus associated with canine allergic dermatitis and the clinical manifestations of atopic dermatitis.
Uniquely, the new treatment inhibits the JAK enzyme, a protein that is integral to the signalling pathway of cytokines that are pro-inflammatory or have a role in allergic and itch response.
According to the company, pruritus affects about one in six dogs whose owners seek veterinary help, and about half of all itchy dogs will have an underlying allergic skin condition for which the new product would be indicated.
Zoetis says that because Apoquel targets the specific pathways of pruritus (itch) and inflammation, it is less likely to cause unwanted side effects than glucocorticoids and demonstrates anti-pruritic efficacy within four hours.
Pascal Prélaud, a dermatology specialist from Paris, who took part in the clinical development programme of Apoquel, said: "When a dog develops an itch related to an allergy, it can be life-disrupting for the dog and the entire family. I've learned firsthand the fundamental difference this treatment can make to a dog and its owners in stopping the itch, but without many of the side-effects that are common with steroids.
Zoetis reports that in clinical trials, Apoquel demonstrated a good safety profile and efficacy for the treatment of pruritus and resulted in improved skin lesions in dogs diagnosed with a number of allergic skin diseases as well as atopic dermatitis and treated either short or long term. The decrease in itch scores was observed by pet owners within 24 hours of administration, and pruritus continued to decrease compared to baseline until the end of the study. Skin lesions scores assessed by veterinarians were significantly improved after one week and continued to improve long term during the studies (four months).
Apoquel is a POM. Apoquel tablets, dosed at 0.4 to 0.6 mg/kg, are administered orally, twice daily for up to 14 days, and then administered once daily for maintenance therapy if medium- to long-term treatment is required, such as in dogs with seasonal skin allergy and atopic dermatitis.
RCVS President Neil Smith has issued a statement in response to the petition by Devon vet Jo Dyer which called for the removal of mandatory house visits from the Code of Professional Conduct and received just shy of 1300 signatures over the past 48 hours.
The statement reads:
"I am delighted to see that so many veterinary surgeons are taking seriously our call for views and evidence on all aspects of the provision of 24-hour emergency cover, including those who have signed up to veterinary surgeon Jo Dyer's petition calling for the removal of 'mandatory house visits' from the Code of Professional Conduct.
"However, I am concerned that the petition is working on a misunderstanding. Veterinary surgeons are not mandated to attend away from the practice just because an owner has requested a visit. It is a professional decision based on a range of factors.
"In fact, paragraph 3.13 of the Supporting Guidance to the Code of Professional Conduct states 'Clients may request attendance on a sick or injured animal away from the practice premises and, in some circumstances, it may be desirable to do so. On rare occasions, it may be necessary on clinical or welfare grounds. The decision to attend away from the practice is for the veterinary surgeon, having carefully balanced the needs of the animal against the safety implications of making the visit; a veterinary surgeon is not expected to risk 'life or limb', or that of anyone else, to provide the service.'
"I appreciate that recent disciplinary hearings, especially that of Mr Chikosi, have increased concerns in the profession that vets will be disciplined for not turning out to every single request for a home visit. This is not the case. In order for someone to be taken to a disciplinary hearing for refusing to attend away from the practice, first there needs to be a complaint, and second, the Preliminary Investigation Committee needs to be convinced that the veterinary surgeon could not justify their decision. Such cases are rare. In fact, last year, only 3% of the complaints we received were about 24-hour cover, and not all of those related to home visits.
"Having said this, the number of signatures received on Jo Dyer's petition, and the comments of the signatories, will be fed into the material reviewed by the Standards Committee, alongside formal responses to our call for evidence, and views gathered from animal-owner research. Clearly if so many veterinary surgeons believe that house visits are mandatory in all circumstances, the wording of our guidance needs to be reviewed, at the very least.
"It is likely that any recommendations for change in our 24/7 policy would go to the June meeting of Council, although this timetable is subject to change, depending on the nature of the report from the Standards Committee."
Boehringer Ingelheim Vetmedica has launched trial size Seraquin dispensing strips so clients can try a week's supply of the veterinary joint support supplement for cats and dogs.
Rob Lucy, brand manager for Seraquin, said: "With 9 out of 10 dogs and cats eating Seraquin as a treat, the new dispensing strips are a great way to enable pet owners to experience just how palatable it is."
Each pack of Seraquin dog dispensing strips contains 40 strips of 10 chewable tablets. Each pack of Seraquin cat and small dog dispensing strips contains 10 strips of 20 chewable tablets.
Boehringer says that for each pack of Seraquin dog dispensing strips purchased, veterinary practices will get one pack of Seraquin cat and small dog dispensing strips free. In addition, the company will make a £20 donation to Hounds for Heroes on behalf of each practice that orders Seraquin Dispensing Boxes. The donations will help to buy, train and support an assistance dog for an injured or disabled man or woman from the UK armed forces or civilian emergency services.
For further information, contact your Boehringer territory manager.
Elanco has announced the results of a survey it conducted amongst European dermatology diplomates which found that nearly 90% of them consider Comfortis (spinosad) is the first choice of flea control for cats and dogs.
The research was conducted at the European Society of Veterinary Dermatology (ESVD) and European College of Veterinary Dermatology (ECVD) Congress 2013. 49 Dip ESVD holders from around Europe were asked:
Research has shown that dermatological cases account for approximately 20% of small animal consultations conducted by general practitioners1. According to Elanco, further industry investigations have found that skin diseases are two to three times more common than the next disease category, and dermatological problems are a common secondary reason for an examination.
Anna Jackson, national veterinary manager at Elanco Companion Animal Health, said: “Skin diseases are a huge part of a practicing vet’s workload and one which can prove challenging to effectively address. By creating a fast acting oral flea control product that can work alongside other topical dermatological treatments, we’re helping to alleviate the discomfort and consequences of flea allergy dermatitis, which is one of the most common causes of skin disease. It’s fantastic to receive such strong endorsements from some of the leading dermatologists in Europe and this underlines the benefits of using Comfortis for flea control.”
Reference
Petplan has been voted Best Insurance Provider in the seventh annual Your Cat and Your Dog Product Awards.
This is the sixth consecutive year Your Cat and Your Dog readers have voted Petplan number one, in response to a survey completed by thousands of pet owners.
Isabella von Mesterhazy, Head of Marketing at Petplan said: "To be independently voted number one provider by pet owners means so much, particularly as this is the sixth time we have been awarded this honour.
"Petplan's Covered for Life policy is the original lifetime policy - we were the first insurer to offer this type of policy and cover. This, combined with over 36 years' experience in the pet insurance marketplace means Petplan truly understands what pet owners need and want from their pet insurance. We settle 97% of claims successfully and 90% of customers renew each year. Moreover, we paid out over £180 million in claims in 2013, the majority directly with the vet, which leaves owners able to concentrate on supporting their pet back to full health rather than worrying about vet bills."
The Animal Health Trust is calling for all small animal practitioners to help with a prospective survey study on breed differences in clinical features in canine hyperadrenocorticism.
The Trust is asking vets that diagnose a case of spontaneous hyperadrenocorticism to complete an online questionnaire at bit.ly/aht-cushing.
The questionnaire should take 10 minutes to complete and all the information will be processed anonymously. Each questionnaire submitted has a chance to win a £100 Amazon voucher. On completing the survey, participants can ask to be notified of the results of this study when available.
Researchers say they hope this data will help veterinary surgeons in the diagnosis of canine hyperadrenocorticism, and ask that everyone helps spread the word about the study.
If you have any queries about this study, please contact michael.bennaim@aht.org.uk
Veterinary Practices are being urged to come forward and enter their PR campaigns for this year's Veterinary Marketing Association (VMA) PR Award for 2013.
The aim of the PR Award is to recognise the value that media and public relations can add to the marketing mix, says award sponsor, Jane Manning of Splash Communications.
Jane said: "PR comes in many forms, including social media, but you don't always need big budgets to deliver the most effective campaigns. Regional press, newsletters and radio or local TV broadcasts are all ways that vets can promote their business or specific initiatives. We know that many practices are highly active across many of these mediums, helping to promote the practice or specific initiatives to a local audience."
She added: "The award is given to the company, organisation or veterinary practice that has delivered the most innovative and effective PR campaign during the previous year, as judged by a panel of industry professionals. This can be a single 'one-off' event or article, or a sustained campaign over a given period".
The winner and two highly commended entries will be announced at the VMA Awards on Friday 14th March 2014, at The London Lancaster Hotel.
Deadline for entries is Friday 31st January 2014. Further information on the awards and ticket application forms are available at the VMA's website: www.vma.org.uk or by calling 0844 561 6157.